Skip to content

  • Home
  • About Ampersand
  • About PRIM&R
  • Posts
  • Contact Us
  • Policies

Tag: news

> news
Uncategorized

Cancer drugs raise further questions in ongoing ethical debate

(PRIM&R) Public Responsibility in Medicine and Research

An article in a recent edition of the New York Times examines the struggle between treating patients responsibly, and gathering…

Read More
Uncategorized

Federal stem cell funding allowed to resume

(PRIM&R) Public Responsibility in Medicine and Research

This afternoon, a federal appeals court temporarily restored federal funding for stem cell research pending appeal of a U.S. District…

Read More
Uncategorized

Judge halts federal stem cell aid

(PRIM&R) Public Responsibility in Medicine and Research

Yesterday, a federal district judge temporarily blocked the Obama administration’s 2009 executive order that created an opportunity for expanded embryonic…

Read More
Uncategorized

FDA approves first human test of embryonic stem cell treatment

(PRIM&R) Public Responsibility in Medicine and Research

Federal regulators have cleared Geron, a California biotechnology company, to proceed with the world’s first test of embryonic stem cell…

Read More
Uncategorized

Center’s Studies Suspended Due to Impure Injections

(PRIM&R) Public Responsibility in Medicine and Research

A July 17, 2010 New York Times article revealed that research at the Kreitchman PET Center at Columbia University has…

Read More
Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Search the blog
Blogs of Interest

PCORI Blog

RAPS Focus

Bill of Health

BioEdge

ACRP Blog

Posts pagination

  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12

PRIM&R advances the highest ethical standards in the conduct of research. We accomplish this mission through education, membership services, professional certification, public policy initiatives, and community building.